NFKB1 and breast cancer: Using in vitro and in vivo models, we found that the acquisition of treatment resistance by mouse breast cancer cells was associated with the selection of cells with the constitutively elevated activity of proinflammatory NF-κB and IFN type I pathways and elevated expression of retrotransposons, including L1.